Building the Perfect Pitch
Presenting to VCs Workshop
March 16, 2010 | Palo Alto

Angel Pitch
March 18, 2010 | Palo Alto

Avoiding Online Suicide: New Technologies to Protect or Destroy Your Digital Reputation
Emerging Technology Forum
March 23, 2010 | Palo Alto

Using Social Media Platforms in Business and Enterprise
Software SIG
March 31, 2010 | East Palo Alto

VC Elevator Pitch Roundtable
April 7, 2010 | Palo Alto

Mobile Video 2010 – Where are We?
Wireless VC SIG
April 14, 2010 | Palo Alto

The Life Sciences VC Connection
NEW EVENT
April 22, 2010 | Palo Alto

How Do VCs Select Angel-Backed Deals?
The Angel Showcase
RESCHEDULED | Palo Alto


These events are open to all

7th Annual Investor & Entrepreneur Roundtables
BayBio NEST
March 17, 2010 | Palo Alto

The Seventh Annual Global Technology Symposium
March 24-26, 2010 | Palo Alto

OnDemand: Where the Internet Meets the Enterprise
AlwaysOn
April 19-21, 2010 | Palo Alto
50% discount 'til March 12

NEST Technology Showcase at SRI International
BayBio NEST
April 29, 2010 | Menlo Park

Real Asset Investing Forum
Opal Group
June 2010 | San Francisco, CA

Private Equity Summit for Institutional Investors
Opal Group
June 2010 | San Francisco, CA

21st Annual Venture Capital Investing Conference
IBF Conferences
June 9-10, 2010 | San Francisco

These events are restricted

IFC'S 12TH Annual Global Private Equity Conference in Association with EMPEA
Returning to Growth: Private Equity in Emerging Markets
IBF Conferences
May 11-12, 2010 | Washington, D.C.

Emerging Managers Summit
Opal Group
May 12-14, 2010 | Chicago, IL

9TH Annual MedTech Investing presented in conjunction with Lifescience Alley™
IBF Conferences
May 19-20, 2010 | Minneapolis, MN

Investment Trends Summit
Opal Group
June 16-18, 2010 | Santa Barbara, CA

Limited Partners Summit New York 2010
Dow Jones
June 22-23, 2010 | Grand Hyatt, New York, NY

These events are restricted

Life Sciences : Innovations Series
Arresting – and Enhancing -- the Aging Process
October 2, 2007 | 7:30–9:30am | Quadrus Center | 2400 Sand Hill Rd.| Menlo Park
Event Sponsor: O’Melveny & Myers LLP

Can we arrest the aging process, offset disease -- and even extend longevity significantly? And, what’s the future potential for drugs to treat or prevent a wide variety of diseases related to aging? Join noted aging authority UCSF Professor Cynthia Kenyon, PhD and Elixir Pharmaceuticals CEO William “Bill” Heiden as they provide insights into the current research on aging, discuss the potential for life enhancing changes and share thoughts on the future for new commercial products.

  • How recent experiments in mammals hint that similar genetic pathways may affect human aging as well  -- and the potential for new drugs
  • How disease onset can be offset by preventing cellular damage
  • What is the current stage of commercial product development—and what are the enormous unmet needs and the future potential for the development of new drugs


About our Speakers:
Since 1986, Cynthia Kenyon, Ph.D. has taught at theUniversity of California, San Francisco, where she is the Herbert BoyerDistinguished Professor of Biochemistry and Biophysics. She joined UCSFafter a post-doctoral fellowship at the Medical Research CouncilLaboratory of Molecular Biology in Cambridge, England. Dr. Kenyonreceived a Ph.D. from the Massachusetts Institute of Technology, is amember of the American Academy of Arts and Sciences and has authored orco-authored more than 50 publications, including a recent article inNature about the regulation of lifespan in C. elegans.

Alan Cash is CEO of Terra Biological LLC. As CEO, Mr. Cash is involved in the research, regulatory acceptance, marketing and sales of a calorie restriction mimetic that has been shown to increase lifespan of various short-lived laboratory animals.  Human clinical trials confirm the product’s ability to reduce fasting glucose levels (consistent with calorie restriction). The product, benaGeneTM, is sold in Canada and Europe as a nutritional supplement, with anticipation of sales in the USA in third quarter, 2008.

Previously Mr. Cash started, operated and sold several high tech companies.  Most recently he sold Terra-Kleen Response Group, Inc. to a Canadian Public company.  Terra-Kleen provided a high tech solution for soil contaminated with PCBs and dioxins.  The technology was licensed to Mitsubishi Heavy Industries (Tokyo, Japan) and Veolia Environmental (Sydney, Australia).  During Mr. Cash’s management, the company was recognized by the White House, was listed on the INC. 500, received awards from Deloitte & Touch Technology Fast 50, Ernst &Young Entrepreneur of the Year, Environmental Business Journal, Zweig-White Hot firm list and was recognized at one of the top 50 growth firms in Southern California. Mr. Cash holds both an MS and BS in Physics.

Agenda:
Doors Open 7:30 a.m.
Registration and Breakfast 7:30-8:00
Program 8:00-9:30 a.m
 
$45 VC Taskforce members
$55 Affiliates
$67 General
(If space is available, door registration is an additional $10)
Seating is limited; register early.

Life Science Innovations Series:
The inaugural of a new series initiated by VC Taskforce and sponsored by O’Melveny & Myers. Life Sciences Innovations is designed to enrich the discussions among researchers, entrepreneurs and venture and angel groups about evolving life sciences innovations.     

Science Innovations Program Chair:

Kathleen Imhoff, Pacific BioFacilities

Program Committee:    
Nat Baker                               
Agustin De la Calle                        
Rohit Gupta
David Hutton
Mary Napier
Atta Pilrim
Charlotte Rogers

If you have any questions please contact
Nat Baker, Direct Phone 415.722.6893

 
Membership
Join VC Taskforce!
Be a part of our pro-active
venture community


Thank You to All Our Sponsors

Berger/Lewis
BoxCaster Podcast
Eventbee
NTR Lab
The Oya Group Marketing
Pacific Business Centers
RampUp Solutions Inc
Skyridge Productions
Venture Deal
WeNotify.net
Wilson Sonsini Goodrich & Rosati




Apax Partners
DLA Piper
Dow Jones
Garage Technology Ventures
IBF Conferences
Latham & Watkins
Morgan, Lewis & Bockius LLP
Pillsbury Winthrop
PricewaterhouseCoopers
RoseRyan
Wilson Sonsini Goodrich & Rosati
WorkIt -The Hub for Technology Startup
Wireless Communications Alliance


Recent Programs
VC Elevator Pitch Roundtable
March 3, 2010 | Palo Alto

Angel Pitch
February 18, 2010 | Palo Alto

VC Elevator Pitch Roundtable
February 3, 2010 | Palo Alto

Capitalizing on Corporate Venture Capital and Strategic Investor Relationships
Corporate Venture Capital SIG
January 28, 2010 | Palo Alto

Crafting Your Mantra: How to distill the essence of your value proposition
January 26, 2010 | Palo Alto

Angel Pitch
January 21, 2010 | Palo Alto

VC Connect: Ask A VC
January 20, 2010 | Palo Alto

The Elevator Pitch Roundtable
January 6, 2010 | Palo Alto

The Elevator Pitch Roundtable
December 2, 2009 | Palo Alto

Building the Perfect Company Presentation
Presenting to VCs
MORNING WORKSHOP
December 1, 2009 | Palo Alto

Home  |  About VC Task Force  |  Contact Us  |  Programs  |  In the News  |  Participating Venture Capitalists
In-Kind Sponsors
RumpUp Solutions NTR Lab Wilson Sonsini Goodrich & Rosati Pacific Business Centers Oya Group We Notify Boxcaster Berger/Lewis
© 2001-2008 VC Taskforce
Site Designed by 101 Color, LLC & Web development: NTR Lab